EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target

Neuroreport. 2010 Nov 17;21(16):1018-22. doi: 10.1097/WNR.0b013e32833f19f2.

Abstract

Epidermal growth factor module-containing mucin-like hormone receptor-3 (EMR-3) is a G-protein coupled receptor with unknown ligand and cellular function. Upregulation of EMR-3 in glioblastoma (GBM) multiforme is associated with poor survival. We investigated the expression patterns and functional significance of EMR-3 in GBM using immunohistochemistry, western blot, reverse transcription PCR, and small interfering RNA knockdown in proliferation and invasion assays. EMR-3 is variably expressed in primary human GBM tissues and cell lines. Knocking down EMR-3 has no impact on cellular proliferation, but decreases cellular invasion by greater than 3-fold. EMR-3 is a potential mediator of cellular invasion in GBM. Given the poor survival associated with high levels of EMR-3 expression in glioma patients, our results provide impetus to explore EMR-3 as a potential therapeutic target.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / genetics
  • Brain Neoplasms / genetics
  • Brain Neoplasms / metabolism*
  • Brain Neoplasms / pathology
  • Cell Line, Tumor
  • Cell Proliferation
  • Diagnosis, Differential
  • Gene Expression Regulation, Neoplastic / genetics
  • Glioblastoma / genetics
  • Glioblastoma / metabolism*
  • Glioblastoma / physiopathology
  • Humans
  • Neoplasm Invasiveness / genetics
  • Neoplasm Invasiveness / pathology*
  • Phenotype
  • RNA Interference / physiology
  • Receptors, G-Protein-Coupled / biosynthesis
  • Receptors, G-Protein-Coupled / genetics
  • Receptors, G-Protein-Coupled / metabolism*
  • Receptors, Peptide / biosynthesis
  • Receptors, Peptide / genetics
  • Receptors, Peptide / metabolism*
  • Survival Rate / trends

Substances

  • ADGRE3 protein, human
  • Biomarkers, Tumor
  • Receptors, G-Protein-Coupled
  • Receptors, Peptide